CTI BioPharma Corp (CTIC) is down Thursday morning, with the stock falling -1.03% in pre-market trading to 5.77. CTIC's short-term technical score of 93 indicates that the stock has traded more bullishly over the last month than 93% of stocks on the market. In the Biotechnology industry, which ranks 117 out of 146 industries, CTIC ranks higher than 93% of stocks. CTI BioPharma Corp has fallen 6.72% over the past month, closing at $6.13 on July 21. During this period of time, the stock fell as low as $5.41 and as high as $7.80. CTIC has an average analyst recommendation of Strong Buy. The company has an average price target of $9.58.
News Home
CTI BioPharma Corp has a Long-Term Technical rank of 89. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 11% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, CTIC ranks better than 83% of stocks.
CTI BioPharma Corp (CTIC) Down 1.03% in Premarket Trading
Mentioned in this article
CTIC has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on CTIC!